- Home
- PRLD vs ZTEK Comparison
PRLD vs ZTEK Comparison
Compare PRLD & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLD | ZTEK |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 78.2M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PRLD | ZTEK |
|---|---|---|
| Price | $3.41 | $0.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.67 | N/A |
| AVG Volume (30 Days) | ★ 315.8K | 129.9K |
| Earning Date | 06-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,140,000.00 | N/A |
| Revenue This Year | $320.10 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 73.43 | N/A |
| 52 Week Low | $0.61 | $0.54 |
| 52 Week High | $4.19 | $1.84 |
Technical Indicators
Market Signals| Indicator | PRLD | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 61.49 | 48.13 |
| Support Level | $0.99 | $0.63 |
| Resistance Level | $4.19 | $0.75 |
| Average True Range (ATR) | 0.37 | 0.05 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 58.90 | 76.15 |
Price Performance
Historical ComparisonAbout PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.